Effect of diphenoxylate with atropine sulfate on the bioavailability of quinidine sulfate in healthy subjects. 1988

J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
Massachusetts College of Pharmacy and Allied Health, Sciences, Boston.

UI MeSH Term Description Entries
D007540 Isonipecotic Acids Acids, Isonipecotic
D008297 Male Males
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004157 Diphenoxylate A MEPERIDINE congener used as an antidiarrheal, usually in combination with ATROPINE. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity. Diphenoxylate Hydrochloride,Diphenoxylate Monohydrochloride,Hydrochloride, Diphenoxylate,Monohydrochloride, Diphenoxylate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001285 Atropine An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine. AtroPen,Atropin Augenöl,Atropine Sulfate,Atropine Sulfate Anhydrous,Atropinol,Anhydrous, Atropine Sulfate,Augenöl, Atropin,Sulfate Anhydrous, Atropine,Sulfate, Atropine
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
January 1979, Journal of clinical pharmacology,
J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
March 1991, American journal of ophthalmology,
J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
November 1977, Journal of pharmaceutical sciences,
J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
January 1987, The Journal of international medical research,
J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
November 2012, European journal of clinical pharmacology,
J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
December 1990, Nihon juigaku zasshi. The Japanese journal of veterinary science,
J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
January 1983, European journal of clinical pharmacology,
J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
January 1989, Biopharmaceutics & drug disposition,
J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
January 1982, Journal of clinical pharmacology,
J J Ponzillo, and J M Scavone, and R P Paone, and G P Lewis, and C M Rayment, and W E Fitzsimmons
January 1974, Le Journal medical libanais. The Lebanese medical journal,
Copied contents to your clipboard!